Presentation is loading. Please wait.

Presentation is loading. Please wait.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Molecular Diagnostics Market share to surpass USD 4 billion by 2023.

Similar presentations


Presentation on theme: "© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Molecular Diagnostics Market share to surpass USD 4 billion by 2023."— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 U.S. Molecular Diagnostics Market share to surpass USD 4 billion by 2023:Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Global Molecular Diagnostics Market size is driven by increasing geriatric population and associated rise in chronic disease prevalence. According to UN estimates, population with more than 65 years of age should witness substantial increase from 901 million in 2015 to 2.1 billion by 2050.  Emergence of technologically advanced diagnostic products should offer promising market growth opportunities for industry players. Furthermore, growing demand for point of care diagnostics (PoC) will accelerate molecular diagnostics market growth.  Growing adoption of personalized medicines and companion diagnostics, improved acceptance of diagnostic devices by healthcare practitioners, and increasing research funding to conduct medical diagnostics clinical studies, should propel growth.  HPV is anticipated to expand at impressive 9.8% CAGR from 2016 to 2023. Growing HPV prevalence should provide lucrative market expansion opportunities to industry participants. As per CDC, around 79 million people are infected with HPV in the U.S. alone. Key Insights from Molecular Diagnostics Market :

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  PCR held more than 45% of molecular diagnostics market share in 2016. Emergence of new technologies such as genetic sequencing and in-situ hybridization should hinder growth over the forecast period.  U.S. molecular diagnostics market size should surpass USD 4 billion by 2023 owing to improved healthcare infrastructure, high technology adoption and increased patient awareness regarding early disease diagnosis.  India molecular diagnostics market size should manifest robust growth attributed to huge patient numbers suffering from infectious diseases, effective preventive healthcare policies, rapid economic development and improvement in healthcare infrastructure throughout the country.  Key industry participants include Alere, Abbott Laboratories, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, bioMerieux, Cepheid, Dako, Hologic (Gen Probe), Danaher Corporation, Johnson & Johnson, Qiagen, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics and Sysmex. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Germany Molecular diagnostics market size, by technology, 2012-2023 (USD Million)

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Molecular Diagnostics Market @ http://bit.ly/2oUDIou http://bit.ly/2oUDIou Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/434 https://www.gminsights.com/request-sample/detail/434

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media:


Download ppt "© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Molecular Diagnostics Market share to surpass USD 4 billion by 2023."

Similar presentations


Ads by Google